Freshly obtained human placentas from various periods of gestation were quantitatively analysed for their immunoreactive oxytocin (OT) content and its biological activity was examined in a Magnus apparatus by utilizing rat uterus.
Previous studies (Nakazawa et al., 1982 (Nakazawa et al., , 1983 have demonstrated that considerable amounts of immunoreactive oxytocin (OT) exist in the human placental tissue from various periods of gestation.
Since detection of a peptide by immunocytochemistry and immunoassay techniques does not provide absolute identification of this peptide with the original peptide in diverse organs, further studies are usually required to draw a definite conclusion.
Keeping these facts in mind, the present study was designed to investigate changes in immunoreactive OT in the human placenta through pregnancy in comparison with plasma levels of OT and binding proteins of the posterior pituitary hormones, estrogen stimulated neurophysin (ESN) and nicotine stimulated neurophysin (NSN). Furthermore, to elucidate the physiological role of immunoreactive OT in the placental extract, its bioactivity was examined in an in vitro Magnus apparatus by utilizing rat uterine muscles.
Materials and Methods
Placentas Kaplan and Grunbach, 1964) , placental ACTH (Genazzani et al., 1975) , TSH (Hershman and Starnes, 1969) , as well as hCG (Halban, 1905) and several other peptides. However, few studies on human placental oxytocin have been reported. Cantone and Martini reported oxytocic activity in placental tissue (1954), but no further detailed study has been reported on the OTlike effect of the placental peptide on the uterine muscle. The present study clearly demonstrated that immunoreactive OT was detectable in the human placenta and the total content of immunoreactive OT in this tissue increased from the beginning of pregnancy to term. It is not possible in the present study to tell whether the source of plasma OT is the posterior pituitary or the placenta, through plasma levels of immunoreactive OT and ESN increased concomitantly to term. Krieger (1982) reported that placental concentrations of pituitary-like peptides are markedly less than those of their pituitary counterpart, usually several orders of magnitude lower than reported for their original sites of production. However it is of interest that the content of immuno-reactive OT in the placenta was significantly higher than its total content in the posterior pituitary.
It should be realized that the detection At present, it is still an emigma why an oxytocin-like substance exists in the placenta. Pearse (1977) has postulated that all tissues including the placenta which contain similar peptides are of neural crest origin, because the yolk sac endoderm arises as a layer of ectoblast continuous with the ectoblast of neural plate. Therefore the placenta can be developed with this neurally programmed region and some of its cell functions can be similarly programmed.
There is little information with regard to any mechanism of synthesis, release and degradation of placental oxytocin, however an investigation on the chemical composition of an OT degrading enzyme, oxytocinase in the placenta (Yman, 1970) , encourages our present study, because it is more physiological that a hormone and its linked enzyme co-exist in same tissue or organ. 
